- Home
- RNXT vs WVVI Comparison
RNXT vs WVVI Comparison
Compare RNXT & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- WVVI
- Stock Information
- Founded
- RNXT 2012
- WVVI 1983
- Country
- RNXT United States
- WVVI United States
- Employees
- RNXT N/A
- WVVI N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- RNXT Health Care
- WVVI Consumer Staples
- Exchange
- RNXT Nasdaq
- WVVI Nasdaq
- Market Cap
- RNXT 31.6M
- WVVI 29.8M
- IPO Year
- RNXT 2021
- WVVI N/A
- Fundamental
- Price
- RNXT $1.03
- WVVI $6.09
- Analyst Decision
- RNXT Strong Buy
- WVVI
- Analyst Count
- RNXT 1
- WVVI 0
- Target Price
- RNXT $9.00
- WVVI N/A
- AVG Volume (30 Days)
- RNXT 214.8K
- WVVI 9.6K
- Earning Date
- RNXT 03-31-2025
- WVVI 03-25-2025
- Dividend Yield
- RNXT N/A
- WVVI N/A
- EPS Growth
- RNXT N/A
- WVVI N/A
- EPS
- RNXT N/A
- WVVI N/A
- Revenue
- RNXT N/A
- WVVI $39,259,016.00
- Revenue This Year
- RNXT N/A
- WVVI N/A
- Revenue Next Year
- RNXT N/A
- WVVI N/A
- P/E Ratio
- RNXT N/A
- WVVI N/A
- Revenue Growth
- RNXT N/A
- WVVI N/A
- 52 Week Low
- RNXT $0.77
- WVVI $3.17
- 52 Week High
- RNXT $1.86
- WVVI $6.33
- Technical
- Relative Strength Index (RSI)
- RNXT 35.37
- WVVI 65.31
- Support Level
- RNXT $1.00
- WVVI $5.70
- Resistance Level
- RNXT $1.18
- WVVI $6.20
- Average True Range (ATR)
- RNXT 0.10
- WVVI 0.34
- MACD
- RNXT -0.03
- WVVI -0.07
- Stochastic Oscillator
- RNXT 6.00
- WVVI 72.41
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.